These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25859945)

  • 21. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
    Barelier S; Krimm I
    Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of biomolecular interactions with complex-binding small molecules.
    Cai Z; Greene MI; Berezov A
    Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Protein Communication to Drug Discovery.
    Persico M; Di Dato A; Orteca N; Fattorusso C; Novellino E; Andreoli M; Ferlini C
    Curr Top Med Chem; 2015; 15(20):2019-31. PubMed ID: 25986690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugging challenging targets using fragment-based approaches.
    Coyne AG; Scott DE; Abell C
    Curr Opin Chem Biol; 2010 Jun; 14(3):299-307. PubMed ID: 20223699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening protein-small molecule interactions by NMR.
    Davis B
    Methods Mol Biol; 2013; 1008():389-413. PubMed ID: 23729260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
    Magee TV
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2461-8. PubMed ID: 25971770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using fragment-based technologies to target protein-protein interactions.
    Bower JF; Pannifer A
    Curr Pharm Des; 2012; 18(30):4685-96. PubMed ID: 22650253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.
    Zhang X; Betzi S; Morelli X; Roche P
    Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based virtual screening for novel ligands.
    Pitt WR; Calmiano MD; Kroeplien B; Taylor RD; Turner JP; King MA
    Methods Mol Biol; 2013; 1008():501-19. PubMed ID: 23729265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein Interfaces as Targets in Drug Discovery.
    Fattorusso C; Persico M
    Curr Top Med Chem; 2015; 15(20):2003-4. PubMed ID: 26156196
    [No Abstract]   [Full Text] [Related]  

  • 33. Unbiased binding assays for discovering small-molecule probes and drugs.
    Kemp MM; Weïwer M; Koehler AN
    Bioorg Med Chem; 2012 Mar; 20(6):1979-89. PubMed ID: 22230199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tethering: fragment-based drug discovery.
    Erlanson DA; Wells JA; Braisted AC
    Annu Rev Biophys Biomol Struct; 2004; 33():199-223. PubMed ID: 15139811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-protein interactions: network analysis and applications in drug discovery.
    Bultinck J; Lievens S; Tavernier J
    Curr Pharm Des; 2012; 18(30):4619-29. PubMed ID: 22650261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a rule-based method for the assessment of protein druggability.
    Perola E; Herman L; Weiss J
    J Chem Inf Model; 2012 Apr; 52(4):1027-38. PubMed ID: 22448735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of small molecule inhibitors of protein-protein interactions using combined ligand and target score normalization.
    Casey FP; Pihan E; Shields DC
    J Chem Inf Model; 2009 Dec; 49(12):2708-17. PubMed ID: 19994847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.